Eli Lilly seeking fast-track FDA approval for obesity drug tirzepatide [MOC2jfEy5iI]

Eli Lilly seeking fast-track FDA approval for obesity drug tirzepatide [MOC2jfEy5iI]

| 1h 28m 28s | Video has closed captioning.

Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more. #elililly #fda #news "CBS Evening News with Norah O'Donnell" delivers the latest news and original reporting, and goes beyond the headlines with context and depth. Catch the "CBS Evening News" weeknights at 6:30 p.m. ET on the CBS Television Network and at 10 p.m. ET on the CBS News app. Subscribe to the "CBS Evening News" YouTube channel: Watch full episodes of "CBS Evening News": Follow "CBS Evening News" on Instagram: Like "CBS Evening News" on Facebook: Follow "CBS Evening News" on Twitter: Download the CBS News app: Try Paramount+ free: For video licensing inquiries, contact: [email protected] #beat weight loss gummies #mega green tea diet pills #oprah new diet pill #keto actv gummies #how to use weight loss gummies